Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Studies on Mechanisms of Low Emetogenicity of YM976, a Novel Phosphodiesterase Type 4 Inhibitor
Motonori Aoki, Masahiro Fukunaga, Tohru Sugimoto, Yasuno Hirano, Miki Kobayashi, Kazuo Honda and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1142-1149;
Motonori Aoki
Masahiro Fukunaga
Tohru Sugimoto
Yasuno Hirano
Miki Kobayashi
Kazuo Honda
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 3
1 Sep 2001
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Studies on Mechanisms of Low Emetogenicity of YM976, a Novel Phosphodiesterase Type 4 Inhibitor
Motonori Aoki, Masahiro Fukunaga, Tohru Sugimoto, Yasuno Hirano, Miki Kobayashi, Kazuo Honda and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1142-1149;
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Studies on Mechanisms of Low Emetogenicity of YM976, a Novel Phosphodiesterase Type 4 Inhibitor
Motonori Aoki, Masahiro Fukunaga, Tohru Sugimoto, Yasuno Hirano, Miki Kobayashi, Kazuo Honda and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1142-1149;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement